Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             54 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 Adding hetrombopag to cyclosporine a improved response of patients with newly diagnosed transfusion-dependent non-severe aplastic anemia Shen, Shupei

103 10 p. 4247-4249
artikel
2 Adult acute leukemia patients with gram-negative bacteria bloodstream infection: Risk factors and outcomes of antibiotic-resistant bacteria Wang, Jinjin

103 10 p. 4021-4031
artikel
3 Advances in the ocular complications after hematopoietic stem cell transplantation Lv, Xiaoli

103 10 p. 3867-3880
artikel
4 Analysis of the occurrence and liver function characteristics of arsenic-associated liver injury during the treatment of pediatric patients with acute promyelocytic leukemia Yang, Yuxuan

103 10 p. 3999-4007
artikel
5 Antiviral prophylaxis to prevent herpes simplex virus (HSV) and varicella zoster virus (VZV) reactivation in adult patients with newly diagnosed acute leukemia: results of a survey submitted to Italian centers belonging to SEIFEM (Sorveglianza Epidemiologica Infezioni nelle Emopatie) group Forghieri, Fabio

103 10 p. 4329-4332
artikel
6 Auto-hematopoietic stem cell transplantation or chemotherapy? Meta-analysis of clinical choice for AML Ge, Songyu

103 10 p. 3855-3866
artikel
7 Benefit of consolidative radiation in patients with extranodal limited-stage diffuse large B-cell lymphoma: a multicenter retrospective study in China Weng, Huawei

103 10 p. 4231-4237
artikel
8 Bibliometric analysis of worldwide research on Polycythemia Vera in the 21st century Cui, Zhengjiu

103 10 p. 3905-3920
artikel
9 Carfilzomib-induced thrombotic microangiopathy (TMA) refractory to eculizumab: A case report and literature review Meseha, Mina

103 10 p. 4313-4317
artikel
10 Chromothripsis in myeloid malignancies Chen, Chien-Yuan

103 10 p. 3955-3962
artikel
11 Circulating tumor DNA assisting lymphoma genetic feature profiling and identification Wang, Hongbiao

103 10 p. 4135-4144
artikel
12 Clinical characteristics of membranous nephropathy after allogeneic hematopoietic stem cell transplantation: A real-world multicenter study Jin, Yue

103 10 p. 4261-4270
artikel
13 Clinical management of patients diagnosed with acute myeloid leukemia treated with venetoclax in combination with hypomethylating agents after achieving a response: a real-life study Jiménez-Vicente, Carlos

103 10 p. 4033-4043
artikel
14 Clonal heterogeneity in STAG2m myeloid neoplasms: the Mayo Clinic experience Katamesh, Bahga

103 10 p. 4333-4336
artikel
15 Cold case: COVID-19-triggered type 1 cryoglobulinemia van Gils, L.A.J. (Luuk)

103 10 p. 4305-4308
artikel
16 Correction to: Predictive significance of high neutrophil ratio for thrombosis in myeloproliferative neoplasms: JSH-MPN-R18 subanalysis Nagaharu, Keiki

103 10 p. 4349-4350
artikel
17 Dermatologic manifestations of hematologic disorders King, Hannah L.

103 10 p. 3889-3903
artikel
18 Early predictor for differentiation syndrome in newly diagnosed acute promyelocytic leukaemia patients treated with single-agent arsenic trioxide Gao, Yujuan

103 10 p. 3947-3954
artikel
19 Effect of prior lenalidomide or daratumumab exposure on hematopoietic stem cell collection and reconstitution in multiple myeloma Duan, Hongpeng

103 10 p. 3839-3853
artikel
20 Effects of daratumumab on hematopoietic stem cell collection and engraftment in multiple myeloma patients eligible for autologous transplantation: results of the real-life PRIMULA study comparing bortezomib, thalidomide and dexamethasone (VTd) with VTd plus daratumumab (D-VTd) as induction therapy Strafella, Vanda

103 10 p. 4345-4347
artikel
21 Evaluation of the incidence, predictors, risk assessment scores and outcomes of thromboembolism in a cohort of Egyptian NHL patients - Real World Experience El-Ashwah, Shaimaa

103 10 p. 4271-4283
artikel
22 Exploration of ETV6::ABL1-positive AML with concurrent NPM1 and FLT3-ITD mutations Li, Hui-dan

103 10 p. 4295-4304
artikel
23 Flow-cytometry Assessment of DNA content and Immunophenotyping of Immune-cells in Lymph-node-specimens as a Potential Diagnostic Signature of Aggressiveness in B-Non-Hodgkin Lymphomas Azoulay, David

103 10 p. 4203-4210
artikel
24 Genetic and clinical characteristics of acute B-cell lymphoblastic leukemia with MEF2D fusions and report of two novel MEF2D rearrangements Cao, Han-Yu

103 10 p. 4155-4161
artikel
25 Hepatotoxicity as dose-limiting toxicity of the combination of bosutinib and atezolizumab in patients with chronic myeloid leukemia. Results of the ZEROLMC study Pérez-Lamas, Lucía

103 10 p. 4045-4055
artikel
26 Improved efficacy and safety of zanubrutinib versus ibrutinib in patients with relapsed/refractory chronic lymphocytic leukemia (R/R CLL) in China: a subgroup of ALPINE Zhou, Keshu

103 10 p. 4183-4191
artikel
27 Increased ferroptosis of erythrocytes is associated with myelodysplastic syndromes Zhang, Mengying

103 10 p. 4009-4020
artikel
28 Integrated systems biology analysis of acute lymphoblastic leukemia: unveiling molecular signatures and drug repurposing opportunities Budak, Betül

103 10 p. 4121-4134
artikel
29 Intratubular cytoplasmic AL amyloidosis associated with amyloidogenic and crystalline light chain cast nephropathy Husser, François

103 10 p. 4337-4343
artikel
30 IRF4 dysregulation in chronic myelomonocytic leukemia: another brick in the wall of myelodysplastic/myeloproliferative neoplasms Tarantini, Francesco

103 10 p. 4325-4327
artikel
31 Long-term survival outcomes of ‘watch and wait’ in patients with bronchus-associated lymphoid tissue lymphoma: a multicenter real-world data analysis in Korea Kwak, Kunye

103 10 p. 4193-4202
artikel
32 MoReLife – real-life data support the potential of momelotinib as a safe and effective treatment option for cytopenic myelofibrosis patients Jilg, Stefanie

103 10 p. 4065-4077
artikel
33 MTHFR polymorphisms and vitamin B12 deficiency: correlation between mthfr polymorphisms and clinical and laboratory findings Giammarco, Sabrina

103 10 p. 3973-3977
artikel
34 Non-syndromic congenital sideroblastic anaemia; phenotype, and genotype of 15 Indian patients Dongerdiye, Rashmi

103 10 p. 3987-3998
artikel
35 Optimization of immune checkpoint inhibitor treatment planning for relapsed or refractory extranodal NK/T cell lymphoma Yoon, Sang Eun

103 10 p. 4171-4181
artikel
36 Predicting relapsed/refractory disease in childhood hemophagocytic lymphohistiocytosis based on clinical features at diagnosis: A 13-year single-institute retrospective study in Thailand Kusontammarat, Pattranan

103 10 p. 3963-3971
artikel
37 Prognostic value of 18F-FDG PET/CT in patients with relapsed multiple myeloma Guo, Yue-Hong

103 10 p. 4145-4153
artikel
38 Prognostic value of hyperlactatemia and lactate clearance in septic patients with hematological malignancies Inci, Kamil

103 10 p. 4239-4245
artikel
39 Rare case of simultaneous occurrence of chronic neutrophil leukemia and T lymphoblastic lymphoma: case report and literature review Wang, Shi-xuan

103 10 p. 4319-4323
artikel
40 Risk and impact of cytomegalovirus infection in lymphoma patients treated with bendamustine Huang, Jen-Pei

103 10 p. 4099-4109
artikel
41 SARS-CoV-2 infection-induced immune thrombocytopenia: a systematic review of current reports Ono, Ryohei

103 10 p. 3921-3939
artikel
42 Serum hepcidin recalibrated values in Mexican schoolchildren by demographic characteristics, nutritional and infection/inflammation status Mendoza, Eugenia

103 10 p. 3979-3986
artikel
43 Sirolimus is effective for refractory/relapsed idiopathic multicentric Castleman disease: A single-center, retrospective study Liu, Yan-ting

103 10 p. 4223-4230
artikel
44 Successful rechallenge with azacytidine and venetoclax after sustained treatment-free remission in a relapsed acute myeloid leukemia patient: a case report Tamellini, E.

103 10 p. 4309-4311
artikel
45 The clinical efficacy of a daratumumab-based regimen in relapsed/refractory acute leukemia: a single-center experience Dai, Yi

103 10 p. 4057-4063
artikel
46 The life threat in hematopoietic allogeneic stem cell transplantation - an interview and focus group study on health care professionals’ perspectives Reimer, Alinda

103 10 p. 4251-4259
artikel
47 The role of therapeutic plasma exchange in plasma cell disorders Dima, Danai

103 10 p. 3941-3946
artikel
48 Three years follow-up of Venetoclax in advanced-stage, relapsed or refractory AL amyloidosis with cardiac involvement and t(11;14) with BCL2 expression Rieger, Max J.

103 10 p. 4163-4170
artikel
49 Thromboprophylaxis in multiple myeloma: a case-based review with practical guidelines Charalampous, Charalampos

103 10 p. 3881-3888
artikel
50 Transformation risk and associated survival outcome of marginal zone lymphoma: A nationwide study Sun, Xu

103 10 p. 4211-4222
artikel
51 Treatment challenges and outcomes of older patients with acute myeloid leukemia from India Singh, Suvir

103 10 p. 4079-4088
artikel
52 Trends in multiple myeloma incidence, prevalence, mortality, and survival rate in South Korea: a nationwide population-based study Park, Boyoung

103 10 p. 4111-4119
artikel
53 Understanding factors limiting hematopoietic cell transplantation for acute myeloid leukemia patients in Mexico: a comprehensive analysis Solís-Armenta, Rubén

103 10 p. 4089-4097
artikel
54 Venous thromboembolism risk in adults with hereditary thrombophilia: a systematic review and meta-analysis Alnor, Anne B.

103 10 p. 4285-4294
artikel
                             54 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland